David A. Siegel Neuro Pace Inc Transaction History
Two Sigma Advisers, LP
- $47 Billion
- Q3 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Neuro Pace Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 38,100 shares of NPCE stock, worth $489,204. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,100
Previous 40,200
5.22%
Holding current value
$489,204
Previous $447,000
10.96%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NPCE
# of Institutions
84Shares Held
24.6MCall Options Held
20.2KPut Options Held
21.9K-
Polar Capital Holdings PLC London, X03.1MShares$39.8 Million0.17% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.96MShares$38 Million1.88% of portfolio
-
Orbimed Advisors LLC San Diego, CA2.61MShares$33.6 Million0.93% of portfolio
-
Morgan Stanley New York, NY2.55MShares$32.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.44MShares$18.4 Million0.0% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $319M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...